Organigram (OGI) Expected to Announce Earnings on Monday

Organigram (NASDAQ:OGI) will likely be issuing its Q2 2025 quarterly earnings data before the market opens on Monday, May 12th. Analysts expect the company to announce earnings of ($0.03) per share and revenue of $61.27 million for the quarter.

Organigram (NASDAQ:OGI) last issued its quarterly earnings data on Tuesday, February 11th. The company reported ($0.05) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.02). Organigram had a negative return on equity of 8.59% and a negative net margin of 31.69%. On average, analysts expect Organigram to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Organigram Trading Up 6.3 %

Shares of NASDAQ OGI opened at $1.18 on Friday. Organigram has a 12-month low of $0.85 and a 12-month high of $2.11. The firm has a market capitalization of $157.93 million, a price-to-earnings ratio of -3.11 and a beta of 1.35. The firm has a 50 day moving average of $1.05 and a 200 day moving average of $1.36.

Organigram Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.